Powder: -20°C for 3 years | In solvent: -80°C for 1 year
IPI-9119 is an orally active, selective and irreversible FASN inhibitor (IC50 = 0.3 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 163.00 | |
5 mg | In stock | $ 413.00 | |
10 mg | In stock | $ 618.00 | |
25 mg | In stock | $ 985.00 | |
50 mg | In stock | $ 1,330.00 | |
100 mg | In stock | $ 1,790.00 | |
500 mg | In stock | $ 3,590.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 449.00 |
Description | IPI-9119 is an orally active, selective and irreversible FASN inhibitor (IC50 = 0.3 nM). |
Targets&IC50 | FASN:0.3 nM (IC50) |
In vitro | IPI-9119 (0.05, 0.1, 0.25, 0.5, 5 μM; 6 days) inhibits AR-FL and AR-V7 protein expression. IPI-9119 (0.1, 0.5 μM; 6 days) inhibits cell growth and induces cell cycle arrest and apoptosis[1]. IPI-9119 inhibits FASN in cellular occupancy assays (IC50∼10nM) and shows more than 400-fold selectivity against several additional serine hydrolases[2]. |
In vivo | IPI-9119 inhibits tumor growth of castration-resistant prostate cancer in xenografts mouse models[1]. |
Molecular Weight | 495.43 |
Formula | C24H19F2N5O5 |
CAS No. | 1346564-56-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 95 mg/mL (191.75 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
IPI-9119 1346564-56-4 Metabolism Fatty Acid Synthase IPI9119 castration-resistant AR-V7 AR-FL prostate Inhibitor LNCaP-95 inhibit 22Rv1 irreversible C4-2 LNCaP orally Fatty Acid Synthase (FASN) CRPC cancer IPI 9119 inhibitor